-
INTS Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Intensity Therapeutics (INTS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.78 mm | 2.78 mm | 2.78 mm | 2.78 mm | 2.78 mm | 2.78 mm |
Cash burn (monthly) | 153.00 k | 326.00 k | 1.19 mm | 1.39 mm | 5.67 k | 366.83 k |
Cash used (since last report) | 616.58 k | 1.31 mm | 4.80 mm | 5.62 mm | 22.84 k | 1.48 mm |
Cash remaining | 2.17 mm | 1.47 mm | -2.01 mm | -2.84 mm | 2.76 mm | 1.30 mm |
Runway (months of cash) | 14.2 | 4.5 | -1.7 | -2.0 | 486.9 | 3.6 |
13F holders | Current |
---|---|
Total holders | 14 |
Opened positions | 8 |
Closed positions | 1 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 6.39 bn |
Total shares | 1.68 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Sapient Capital | 1.01 mm | $3.86 bn |
Vanguard | 208.89 k | $797.95 mm |
Brown Advisory | 148.11 k | $565.78 mm |
Geode Capital Management | 64.35 k | $245.84 mm |
Sigma Planning | 47.74 k | $182.38 mm |
Mesirow Financial Investment Management | 44.18 k | $168.76 mm |
Blair William & Co | 37.81 k | $144.42 mm |
GTS Securities | 37.29 k | $142.44 mm |
One Charles Private Wealth Services | 31.80 k | $121.48 mm |
BlackRock | 22.11 k | $84.47 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Oct 24 | John M Wesolowski | Stock Option (right to buy Common Stock) Common Stock | Grant | Acquire A | No | No | 3.44 | 70,028 | 240.90 k | 70,028 |
21 Oct 24 | Joseph Talamo | Stock Option (right to buy Common Stock) Common Stock | Grant | Acquire A | No | No | 3.44 | 427,379 | 1.47 mm | 427,379 |
5 Jun 24 | John M Wesolowski | Common Stock, $0.0001 Par Value | Option exercise | Acquire M | No | No | 4 | 1,000 | 4.00 k | 6,691 |
5 Jun 24 | John M Wesolowski | Stock Option (right to buy Common Stock) Common Stock | Option exercise | Dispose M | No | No | 4 | 1,000 | 4.00 k | 14,000 |
14 May 24 | Thomas I H Dubin | Stock Option (right to buy Common Stock) Common Stock | Grant | Acquire A | No | No | 4.42 | 50,000 | 221.00 k | 50,000 |